← All stocks

Revolution Medicines, Inc.

RVMD Mostly scheduled

CIK 0001628171 #590 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$145.52M

$23.68M on a plan · $121.11M straight out of an exercise

Sold at will

$720.49K

1 of 135 sales

Net

−$145.52M

−$720.49K against sales at will

By person

17 insiders · 136 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

GOLDSMITH MARK A

See Remarks

—

$54.20M (43) scheduled

−$54.20M

328,754

0.1534%

$67.66M

+102.4%

Horn Margaret A

Chief Operating Officer

—

$24.26M (14) scheduled

−$24.26M

154,647

0.0722%

$31.83M

+15.7%

Kelsey Stephen Michael

See Remarks

—

$21.44M (12) scheduled

−$21.44M

291,876

0.1362%

$60.07M

+9.8%

Kim Lorence H.

Director

—

$14.97M (14) scheduled

−$14.97M

1,191

0.0006%

$245.12K

−98.3%

Cislini Jeff

General Counsel

—

$14.52M (14) scheduled

−$14.52M

55,907

0.0261%

$11.51M

+20.9%

Mancini Anthony

See Remarks

—

$8.35M (17) scheduled

−$8.35M

43,890

0.0205%

$9.03M

−19.6%

Anders Jack

Chief Financial Officer

—

$6.33M (10) scheduled

−$6.33M

123,269

0.0575%

$25.37M

+23.0%

Patel Sushil

Director

—

$1.05M (9) scheduled

−$1.05M

21,656

0.0101%

$4.46M

+8.6%

Wei Lin

Chief Medical Officer

—

$206.22K (1) scheduled

−$206.22K

101,366

0.0473%

$20.86M

−10.7%

Wang Xiaolin

See Remarks

—

$199.96K (1) scheduled

−$199.96K

116,063

0.0541%

$23.89M

+33.9%

Borisy Alexis

Director

—

2,340,075

1.09%

$481.60M

+0.2%

Schroeder Thilo

Director

—

760,869

0.3550%

$156.59M

—

Horning Sandra

Director

—

97,765

0.0456%

$20.12M

+4.6%

Borellini Flavia

Director

—

26,215

0.0122%

$5.40M

+19.8%

ANDERSON ELIZABETH M

Director

—

24,406

0.0114%

$5.02M

+21.6%

Weber Barbara

Director

—

13,065

0.0061%

$2.69M

−28.5%

Clyburn Frank

Director

—

10,929

0.0051%

$2.25M

+57.7%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 67

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 33

Sales straight out of an exercise 101

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 1,282,173

History held since 14 Feb 2020